{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "17697943", "DateCompleted": {"Year": "2007", "Month": "10", "Day": "31"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [{"Year": "2007", "Month": "06", "Day": "15"}], "Journal": {"ISSN": "0891-5849", "JournalIssue": {"Volume": "43", "Issue": "6", "PubDate": {"Year": "2007", "Month": "Sep", "Day": "15"}}, "Title": "Free radical biology & medicine", "ISOAbbreviation": "Free Radic Biol Med"}, "ArticleTitle": "Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes.", "Pagination": {"StartPage": "987", "EndPage": "992", "MedlinePgn": "987-92"}, "Abstract": {"AbstractText": ["Nitric oxide (NO) is a major regulator of the cardiovascular system. However, the effects of endothelial nitric oxide synthase (eNOS) gene polymorphisms or haplotypes on the circulating concentrations of nitrite (a sensitive marker of NO formation) and cGMP are unknown. Here we examined the effects of eNOS polymorphisms in the promoter region (T-786C), in exon 7 (Glu298Asp), and in intron 4 (4b/4a) and eNOS haplotypes on the plasma levels of nitrite and cGMP. We hypothesized that eNOS haplotypes could have a major impact on NO formation. We genotyped 142 healthy subjects by PCR-RFLP. To assess NO formation, the plasma concentrations of nitrite and cGMP were determined using an ozone-based chemiluminescence assay and an enzyme immunoassay. Haplotypes were inferred using the PHASE 2.1 program. No significant differences were found in age, body mass index, systolic and diastolic arterial blood pressure, heart rate, total cholesterol, triglycerides, cGMP, or nitrite among the genotype groups for the three polymorphisms studied here (all p>0.05). Interestingly, the C-4b-Glu haplotype was associated with lower plasma nitrite concentrations than those found in the other haplotype groups (p<0.05), but not with different cGMP levels (p>0.05). These findings suggest that eNOS gene variants combined within a specific haplotype modulate NO formation, although individual eNOS polymorphisms probably do not have major effects."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Av. Bandeirantes, 3900, 14049-900 Ribeirao Preto, SP, Brazil."}], "Identifier": [], "LastName": "Metzger", "ForeName": "Ingrid F", "Initials": "IF"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Sert\u00f3rio", "ForeName": "Jonas T C", "Initials": "JT"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Tanus-Santos", "ForeName": "Jose E", "Initials": "JE"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Free Radic Biol Med", "NlmUniqueID": "8709159", "ISSNLinking": "0891-5849"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Nitrites"}, {"RegistryNumber": "31C4KY9ESH", "NameOfSubstance": "Nitric Oxide"}, {"RegistryNumber": "EC 1.14.13.39", "NameOfSubstance": "Nitric Oxide Synthase Type III"}, {"RegistryNumber": "H2D2X058MU", "NameOfSubstance": "Cyclic GMP"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adolescent"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["blood"], "DescriptorName": "Cyclic GMP"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Haplotypes"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["biosynthesis"], "DescriptorName": "Nitric Oxide"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Nitric Oxide Synthase Type III"}, {"QualifierName": ["blood"], "DescriptorName": "Nitrites"}, {"QualifierName": [], "DescriptorName": "Polymerase Chain Reaction"}, {"QualifierName": [], "DescriptorName": "Polymorphism, Restriction Fragment Length"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2007", "Month": "4", "Day": "26"}, {"Year": "2007", "Month": "6", "Day": "1"}, {"Year": "2007", "Month": "6", "Day": "8"}, {"Year": "2007", "Month": "8", "Day": "19", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "11", "Day": "1", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "8", "Day": "19", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["17697943", "10.1016/j.freeradbiomed.2007.06.012", "S0891-5849(07)00420-0"]}}], "PubmedBookArticle": []}